middle.news
Starpharma Nets $5.5M Upfront in Genentech Oncology Deal
10:41am on Wednesday 22nd of October, 2025 AEDT
•
Biotechnology
Read Story
Starpharma Nets $5.5M Upfront in Genentech Oncology Deal
10:41am on Wednesday 22nd of October, 2025 AEDT
Key Points
Received USD $5.5 million upfront payment from Genentech
Collaboration to develop dendrimer-drug conjugates for oncology targets
Potential milestone payments up to USD $564 million
Tiered royalties on global net sales included
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Starpharma Holdings (ASX:SPL)
OPEN ARTICLE